Search results
Teddi Mellencamp Thought She Was in Menopause but It Was 'Symptoms from the Copper IUD'
People Magazine· 5 days agoOn April 30, the Real Housewives of Beverly Hills alum posted a video on Instagram asking her...
The morning after pill might NOT work for millions, experts warn
The US Sun· 17 hours agoIF you've had unprotected sex, forgotten to take your contraceptive pill or had a condom break,...
Trump Says Abortion 'Not That Big Of An Issue,' GOP Is 'Party Of Fertilization'
The Huffington Post· 6 hours agoIn one of his most bizarre interviews in recent memory, Donald Trump insisted abortion is “not that...
Whitmer: Want to protect Michigan abortion rights? Reelect Joe Biden. | Opinion
Detroit Free Press via Yahoo News· 17 hours agoOur freedoms depend on it, here in Michigan and everywhere else. I’ll fight like hell, too. Gretchen...
Trump Is Fine With States Monitoring Pregnant Women So They Don't Get Abortions
HuffPost via Yahoo News· 6 days ago“If elected he’ll sign a national abortion ban, allow women who have an abortion to be prosecuted...
Paul F. deLespinasse: Supreme Court's Hobby Lobby decision was based on economic confusion
Gannett via AOL· 5 days agoThe challenges to the contraception requirement in the Affordable Care Act — Obamacare — were based...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
The Longview News-Journal· 1 day agoJohnson & Johnson announced today updated results from an open-label, multicenter, multi-cohort Phase 1 study of the safety and efficacy of TAR-210, an intravesical targeted releasing system ...
Daré Bioscience, Inc. (NASDAQ:DARE) Sees Significant Growth in Short Interest
ETF DAILY NEWS· 4 days agoDaré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 246,900 ...
Gen Z activists look to shake up the anti-abortion movement
The Hill via Yahoo News· 17 hours agoHayden Laye joined protesters outside the Supreme Court last month as the justices weighed a case...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
The Hannibal Courier-Post· 3 days agoFollowing RP, patients who received the treatment regimen showed a 100% biochemical recurrence (BCR)–free rate at 24 months.1 These data were presented today at an Oral Presentation ...